Editor-in-Chief & Deputy Editor 2019-2021

 

Editor-in-Chief:

Nicolas LANTHIER

 

Deputy Editor:

Tim VANUYTSEL

 

 
Surgical outcomes among inflammatory bowel disease patients undergoing colectomy : results from a national databaseSurveillance for hepatocellular carcinoma… A hotly debated issue

Surveillance for hepatocellular carcinoma : compliance and results according to the aetiology of cirrhosis in a cohort of 141 patients

Price: €10,00








(Acta gastroenterol. belg., 2000, 63, 5-9)

January-March Volume 63, fasc. 1

Surveillance for hepatocellular carcinoma : compliance and results according to the aetiology of cirrhosis in a cohort of 141 patients

J. Henrion 1, E. Libon 2, S. De Maeght 1, M. Schapira 1, J.M. Ghilain 1, J.M. Maisin 1, F. Heller 1. - (1) Département de Médecine Interne, Service de Gastroentérologie ; (2) Département de Radiologie.

Surveillance for early detection of hepatocarcinoma (RCC) in patients with cirrhosis is widely accepted. In a cohort of 141 patients with cirrhosis collected during the year 1995, we conducted a surveillance program by performing liver ultrasonography and blood alpha-foetoprotein measurement every 6 months. The median followup was 34 months. This study addressed to two questions : the compliance to the surveillance schedule according to the aetiology of cirrhosis and the results in terms of emergence of HCC and outcome. Aetiology of cirrhosis was alcohol-induced in 86 (61%), HCVrelated in 30 (21%) and from other origins in 25 (18%). Compliance to the program schedule was good in patients with HCV-related cirrhosis (29/30 - 97%) and patients with cirrhosis of Brother origins)> (20/25 - 80%) but was poor in patients with alcoholic cirrhosis (45/86 - 52%). The lack of compliance was significantly linked to the failure to achieve alcohol abstinence. During follow-up, 6 HCC lesions were observed in 6 male patients with median age of 68 years. All 6 HCC were single nodule, less than 4 cm and accessible to percutaneous acetic acid injection. Nevertheless, the outcome was disappointing, four patients dying 3-15 months later (median: 8 months), two of them with extensive HCC. One of the two patients still alive developed extensive HCC, 36 months after percutaneous acetic acid injection.